Profilo
Lynn Gallant worked as Vice President-Clinical Operations at BlueRock Therapeutics Canada ULC and Enveric Biosciences, Inc. Ms. Gallant obtained an undergraduate degree from the University of New England.
Precedenti posizioni note di Lynn Gallant
| Società | Posizione | Fine |
|---|---|---|
| ENVERIC BIOSCIENCES, INC. | Direttore Tecnico/Scientifico/R&S | 01/05/2023 |
BlueRock Therapeutics Canada ULC
 BlueRock Therapeutics Canada ULC BiotechnologyHealth Technology Bluerock Therapeutics engages in development of a pluripotent stem cell-derived myocardiocytes as regenerative cell therapies for restoring electrical and contractile function in patients with myocardial infarction or chronic heart failure. The company was founded by Gordon Keller and Lorenz Studer in 2016 and is headquartered in Toronto, Canada. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Lynn Gallant
| University of New England | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ENVERIC BIOSCIENCES, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
BlueRock Therapeutics Canada ULC
BlueRock Therapeutics Canada ULC BiotechnologyHealth Technology Bluerock Therapeutics engages in development of a pluripotent stem cell-derived myocardiocytes as regenerative cell therapies for restoring electrical and contractile function in patients with myocardial infarction or chronic heart failure. The company was founded by Gordon Keller and Lorenz Studer in 2016 and is headquartered in Toronto, Canada. | Health Technology |
- Borsa valori
- Insiders
- Lynn Gallant
